Cargando…
Transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkers
Peripheral blood is gaining prominence as a noninvasive alternative to tissue biopsy to develop biomarkers for glioblastoma (GBM); however, widely utilized blood-based biomarkers in clinical settings have not yet been identified due to the lack of a robust detection approach. Here, we describe the a...
Autores principales: | Qi, Dan, Geng, Yiqun, Cardenas, Jacob, Gu, Jinghua, Yi, S. Stephen, Huang, Jason H., Fonkem, Ekokobe, Wu, Erxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877004/ https://www.ncbi.nlm.nih.gov/pubmed/36697401 http://dx.doi.org/10.1038/s41525-022-00348-3 |
Ejemplares similares
-
Identification of a panel of genes as a prognostic biomarker for glioblastoma
por: Wang, Fengfei, et al.
Publicado: (2018) -
SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM
por: Mukherjee, Sanjib, et al.
Publicado: (2020) -
Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure
por: Ding, Xuebing, et al.
Publicado: (2015) -
CLRM-02 SINGLE CENTER EXPERIENCE OF DOPAMINE ANTAGONIST ONC-201 FOR RECURRENT H3K27M-MUTANT GLIOBLASTOMA IN ADULTS
por: Ekhator, Chukwuyem, et al.
Publicado: (2022) -
A Single-Center Experience of Dopamine Antagonist ONC201 for Recurrent Histone H3 Lysine 27-to-Methionine (H3K27M)-Mutant Glioblastoma in Adults
por: Ekhator, Chukwuyem, et al.
Publicado: (2022)